Skip to main content

Jet.AI Reports First Quarter 2026 Financial Results

LAS VEGAS, May 15, 2026 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, today announced financial results for the first quarter ended March 31, 2026. General Company UpdateAs of March 31, 2026, the Company had approximately $13.5 million in cash and no debt, compared to $1.8 million in cash as of December 31, 2025. The proposed merger with flyExclusive remains on track for a shareholder vote on June 11, 2026. Subsequent to quarter end, the Company sold one of its HondaJet aircraft in coordination with flyExclusive and in preparation for the anticipated closing of the transaction. Following quarter end, the Company also announced the acquisition of a $5 million economic interest in SpaceX, which has recently been widely...

Continue reading

CytoDyn to Present at the LD Micro Invitational XVI

CFO Robert E. Hoffman to deliver company presentation on May 18 at 10 a.m. PT VANCOUVER, Washington, May 15, 2026 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic triple-negative breast cancer (“mTNBC”) and colorectal cancer (“CRC”), today announced that CFO Robert E. Hoffman will present a corporate overview at the LD Micro Invitational XVI, taking place May 17-19, 2026, at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Presentation Date: Monday, May 18, 2026 Time: 10 a.m. PDT Link to view presentation: Webcast Link – LD Micro Invitational XVI. Mr. Hoffman will...

Continue reading

HeartCore Reports First Quarter 2026 Financial Results

NEW YORK and TOKYO, May 15, 2026 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the first quarter ended March 31, 2026. Recent Operational HighlightsAs of March 31, 2026, HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential public registrations and U.S. exchange listings Regained Nasdaq $1.00 minimum bid price requirement Authorized $2.0 million share repurchase programManagement CommentaryHeartCore CEO Sumitaka Kanno commented: “During the first quarter of 2026, HeartCore continued to advance its strategic focus on financial services and capital markets-related services, with Go IPO remaining the key contributor for coming quarters....

Continue reading

Data Storage Corporation Provides First Quarter 2026 Business Update

Highlights Strategic Expansion into AI Continuity Infrastructure for Regulated Industries Conference Call to be Held Today at 11:00 am ET NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DTST” and the “Company”), today provided a business update for the first quarter ended March 31, 2026, highlighting the Company’s strategic initiatives focused on emerging AI infrastructure opportunities and regulated enterprise continuity solutions. Business Highlights:Launching Sovereign AI Solutions (SaiS): Establishing a wholly owned subsidiary, Sovereign AI Solutions (“SaiS”), focused on developing a purpose-built AI Continuity Control Plane for regulated industries designed to support recovery, validation, and compliance for sovereign AI and AI Factory environments across sectors such as healthcare, financial...

Continue reading

1847 Holdings Reports First Quarter 2026 Financial Results

Company Advances Portfolio Streamlining Strategy, Including Proposed Sale of CMD in Potential $65 Million All-Cash Transaction Operating Expenses from Continuing Operations Declined Approximately 53%; Loss from Operations Improved Approximately 44%; Achieved Positive Cash Flow From Operations NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) — 1847 Holdings LLC (OTC: LBRA) (“1847 Holdings” or the “Company”), a diversified acquisition holding company focused on identifying and monetizing overlooked, deep-value businesses, today announced financial results for the first quarter ended March 31, 2026. During the first quarter of 2026, the Company’s Board of Directors approved a plan to actively market for sale of CMD Inc. (“CMD”), which comprises the CMD segment within the Company’s Construction operations. As a result, CMD has been classified...

Continue reading

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

 Company to continue development of efzofitimod in pulmonary sarcoidosis following Type C meeting with the FDA. Company plans to submit an IND in June 2026 for a Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary sarcoidosis with restrictive lung disease utilizing FVC as primary endpoint and KSQ-Lung as key secondary endpoint. On track to complete enrollment in Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD in the first half of 2026. Ended the first quarter 2026 with $68.3 million in cash, cash equivalents, restricted cash and investments. SAN DIEGO, May 15, 2026 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform,...

Continue reading

Conifex Announces First Quarter 2026 Results

VANCOUVER, British Columbia, May 15, 2026 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”, “we” or “us”) (TSX: CFF) today reported results for the first quarter ended March 31, 2026.  EBITDA* was negative $7.7 million for the quarter compared to EBITDA of negative $12.6 million in the fourth quarter of 2025 and positive EBITDA of $4.9 million in the first quarter of 2025. Net loss was $9.4 million or ($0.23) per share for the quarter versus a net loss of $11.4 million or ($0.28) per share in the previous quarter and net income of $0.6 million or $0.02 per share in the first quarter of 2025. Selected Financial Highlights The following table summarizes our selected financial information for the comparative periods. The financial information reflects results of operations from our Mackenzie sawmill and power plant.Selected Financial...

Continue reading

ContextLogic Holdings Inc. Reports First-Quarter 2026 Financial Results

OAKLAND, Calif., May 15, 2026 (GLOBE NEWSWIRE) — ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the first quarter ended March 31, 2026. Basis of Presentation  ContextLogic completed the acquisition of US Salt on February 26, 2026. To reflect the basis difference as a result of the US Salt acquisition, GAAP results for the first quarter of 2026 are presented in two parts: the period from January 1, 2026 through February 26, 2026 (“Predecessor”), reflecting legacy US Salt, and the period from February 27, 2026 through March 31, 2026 (“Successor”), reflecting ContextLogic Holdings Inc. and US Salt on a consolidated basis. To provide comparable period-over-period information, the Company also presents “Combined” results, a non-GAAP measure that aggregates...

Continue reading

BioCardia Reports First Quarter 2026 Business Highlights and Financial Results

SUNNYVALE, Calif., May 15, 2026 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the first quarter 2026 and filed its quarterly report on Form 10-Q for the three months ended March 31, 2026 with the Securities and Exchange Commission. The Company will also hold a conference call at 4:30 PM ET today in which it will discuss business highlights. Following management’s formal remarks, there will be a question-and-answer session. Recent Business Highlights CardiAMP® autologous cell therapy in ischemic heart failure of reduced ejection fraction (BCDA-01)In February, PMDA provided additional questions for BioCardia, in line with those addressed and discussed in three preliminary...

Continue reading

Bond Provides Business Update and Reports 2026 First Quarter Financial Results

Strategic First Quarter Investments Lay Foundation for Long-Term Growth NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) — Our Bond, Inc. (“Bond”) (NASDAQ: OBAI), the creator of the world’s first AI-powered Preventative Personal Security platform adopted by leading multinational companies, today provided a business update and reported financial results for the first quarter of 2026 ended March 31, 2026. Business HighlightsStrong Enterprise Demand: Continued strong demand from enterprise customers, with deployments expanding across retail, telecommunications, financial services, pharmaceuticals and multinational organizations. Global Expansion: Expanded global footprint, with operations now spanning multiple regions, countries and languages. Multi-Channel Growth Strategy: Continued execution of Bond’s multi-channel go-to-market strategy...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.